pharmaceutical investing Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia
Tenax Therapeutics Activates First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial
pharmaceutical investing Reata Pharmaceuticals Announces First Quarter 2018 Financial Results and an Update on Development Programs
pharmaceutical investing Menlo Therapeutics Announces Results from a Phase 2 Trial of Serlopitant for Pruritus Associated with Atopic Dermatitis
pharmaceutical investing Selecta Biosciences Announces Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update
Cartier Cuts 111.5 g/t Au over 2.0 m at Contact ; Confirms Multiple High-Grade Gold Zones; Extends Drilling at Surface
LAURION Starts defining Gold Mineralization North and Northeast of the Brenbar Shaft, Highlighting 2.68 g/t Au over 1.05 m from 117.6 m to 118.65 m
Significant Gold Discoveries Continue at Golden Gate - Drilling Hits 253.0m @ 1.5 g/t Au from Surface and Open in all Directions Ending in Mineralisation
